Dopeksamin

Dopeksamin
IUPACime
	4-[2-({6-[(2-feniletil)amino]heksil}amino)etil]benzen-1,2-diol
Klinički podaci
Drugs	Internacionalno ime leka
Identifikatori
CAS broj	86197-47-9
ATC kod	C01CA14(WHO)
PubChem	CID55483
ChemSpider	50102
UNII	398E7Z7JB5
KEGG	D03891
ChEMBL	CHEMBL77622
Hemijski podaci
Formula	C22H32N2O2
Molarna masa	429,43 g/mol
	SMILES Oc1ccc(cc1O)CCNCCCCCCNCCc2ccccc2; ;
	InChI InChI=1S/C22H32N2O2/c25-21-11-10-20(18-22(21)26)13-17-24-15-7-2-1-6-14-23-16-12-19-8-4-3-5-9-19/h3-5,8-11,18,23-26H,1-2,6-7,12-17H2; Key:RYBJORHCUPVNMB-UHFFFAOYSA-N;

Reference

^Perrin G, Papazian L, Martin C (1993). „Dopexamine: a new dopaminergic agonist”.Ann Fr Anesth Reanim.12(3): 308—320.PMID 7902685.
^Brown RA; Dixon J; Farmer JB; et al. (1985).„Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors”.Br. J. Pharmacol.85(3): 599—608.PMC1916510 .PMID 2862944.

Molimo Vas, obratite pažnju navažno upozorenje
u vezi sa temama izoblasti medicine (zdravlja).